Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Pfizer, Novavax Rise Premarket; Tesla, Estee Lauder Fall

Published 11/02/2021, 07:57 AM
Updated 11/02/2021, 07:58 AM
© Reuters.

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Tuesday, November 2nd. Please refresh for updates.

  • Tesla (NASDAQ:TSLA) stock fell 4.4% after the National Highway Traffic Safety Administration said the electric car maker is recalling nearly 12,000 U.S. vehicles because of a software communication error. CEO Elon Musk also tweeted that the company’s ground-breaking bulk order from car rental firm Hertz Global  (OTC:HTZZ) hasn't been finalized yet.

  • Pfizer (NYSE:PFE) stock rose 3.1% after the drugmaker raised its full-year sales forecast for its Covid-19 vaccine by 7.5% to $36 billion, helped by deals for booster doses and potential shots in children. The ADRs of its partner BioNTech (NASDAQ:BNTX) rose 2.1%. 

  • Novavax (NASDAQ:NVAX) stock rose 4.1% after the drugmaker secured emergency use approval for its Covid-19 vaccine in Indonesia, its first in any country. The company also said it expects to file a full submission for authorization to the U.S. Food and Drug Administration within in a few weeks.

  • Rogers (NYSE:ROG) stock rose over 30% after industrial materials maker DuPont de Nemours (NYSE:DD), up 0.4%, said it would buy the engineering materials technology maker for about $5.2 billion. 

  • Estee Lauder (NYSE:EL) stock fell 2% after the perfume and makeup manufacturer cut its full-year sales forecast, as the delta variant of Covid-19 ushered in fresh lockdowns in certain markets, particularly China. 

  • Under Armour (NYSE:UA) stock soared 9.2% after the sports apparel maker raised its annual revenue forecast, with consumers still seeking comfortable attire as companies push back their dates for mass returns to the office.

  • Chegg (NYSE:CHGG) stock slumped over 30% after the education technology company disappointed with its third-quarter report, prompting Morgan Stanley (NYSE:MS) to downgrade its investment stance to ‘equal-weight’ from ‘overweight’.

  • Clorox (NYSE:CLX) stock rose 2.2% after the bleach maker posted upbeat first-quarter results, with consumers still fixated on cleanliness in the wake of the pandemic.

  • Avis Budget (NASDAQ:CAR) stock rose 6.3% after the car rental company reported a strong third quarter, as well as announcing a $1 billion increase to its share repurchase program.

  • Simon Property Group (NYSE:SPG) stock rose 3.9% as the mall operator raised its 2021 profit forecast after soundly beating earnings expectations. It also lifted its quarterly dividend.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

 

Latest comments

The pre-market fraud unfolds flagrant as ever.  Assume the position for another day of criminal manipulation, as the US Ponzi Scheme, biggest investment JOKE in history, prepares to defraud America in broad daylight.
Hopefully ill be on the right side of that
hes obviously short lol
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.